These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34027966)

  • 1. [Role of cefditoren in the treatment of community skin and soft tissue infections: revisiting the evidence].
    Cabañero-Navalón MD; García-Bustos V; Salavert Lletí M
    Rev Esp Quimioter; 2021 Jun; 34(3):185-192. PubMed ID: 34027966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefditoren pivoxil: A new oral cephalosporin for skin, soft tissue and respiratory tract infections].
    Hernández-Martin J; Romá E; Salavert M; Doménech L; Poveda JL
    Rev Esp Quimioter; 2006 Sep; 19(3):231-46. PubMed ID: 17099791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefditoren pivoxil.
    Darkes MJ; Plosker GL
    Drugs; 2002; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Bucko AD; Hunt BJ; Kidd SL; Hom R
    Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on cefditoren pivoxil in bacterial infections.
    Wellington K; Curran MP
    Treat Respir Med; 2005; 4(2):149-52. PubMed ID: 15813670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.
    Wellington K; Curran MP
    Drugs; 2004; 64(22):2597-618. PubMed ID: 15516158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefditoren: a clinical overview.
    Giuliano S; Acquasanta A; Martini L; Sbrana F; Flammini S; Tascini C
    New Microbiol; 2023 Feb; 46(1):9-17. PubMed ID: 36853812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
    Jones RN; Pfaller MA; Jacobs MR; Appelbaum PC; Fuchs PC
    Diagn Microbiol Infect Dis; 2001; 41(1-2):1-14. PubMed ID: 11687308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefditoren, a new aminothiazolyl cephalosporin.
    Balbisi EA
    Pharmacotherapy; 2002 Oct; 22(10):1278-93. PubMed ID: 12389878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
    Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
    Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2001 Dec; 23(12):1924-37; discussion 1923. PubMed ID: 11813929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    Sadahira T; Wada K; Araki M; Ishii A; Takamoto A; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y; Kumon H;
    J Antimicrob Chemother; 2017 Feb; 72(2):529-534. PubMed ID: 27733519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcal resistance and oral cephalosporins for skin and skin structure infections.
    Joseph WS
    Cutis; 2004 May; 73(5 Suppl):19-20. PubMed ID: 15182161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
    van Zyl L; le Roux JG; LaFata JA; Volk RS; Palo WA; Flamm R; Hom RC
    Clin Ther; 2002 Nov; 24(11):1840-53. PubMed ID: 12501878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
    Tempera G; Furneri PM; Carlone NA; Cocuzza C; Rigoli R; Musumeci R; Pilloni AP; Prenna M; Tufano MA; Tullio V; Vitali LA; Nicoletti G
    J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring therapeutic options for mild diabetic-related foot infections: a comparative in vitro study of cefditoren versus amoxicillin/clavulanic acid.
    Alou L; Gómez-Rubio E; Giménez Mestre MJ; Alvaro-Afonso FJ; Coronel P; Sevillano D
    Rev Esp Quimioter; 2024 Aug; 37(4):356-359. PubMed ID: 38864830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitis.
    Ozaki T; Nishimura N; Suzuki M; Narita A; Watanabe N; Ahn J; Koyama N; Ushida H; Nakane K; Yasuda N; Funahashi K
    J Infect Chemother; 2008 Jun; 14(3):213-8. PubMed ID: 18574657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of ceftaroline in skin and soft tissue infections].
    Cisneros JM; Barberán J
    Enferm Infecc Microbiol Clin; 2014 Mar; 32 Suppl 2():27-31. PubMed ID: 24702976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.